| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), OMER's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.00M | $13.25M | - | |
| VP | 105.0K | $1.39M | - | |
| VP | 105.0K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2015 | Demopulos Peter A Md | Director | Buy | 3,962 | $12.68 | $50,238.16 | +2.2% | |
| Jul 15, 2015 | Cable Thomas J. | Director | Sell | 2,000 | $18.78 | $37,556.40 | -3.6% | |
| Mar 24, 2015 | Cable Thomas J. | Director | Sell | 2,000 | $24.50 | $48,991.26 | -1.8% |